Hydrex also showed very promising and it went down the tube.
This is the best comparitor. Though, in my opinion the Dynamis deal looks more "real" than the Hydrex one.
Hydrex was for evaluation of a technology. Dynamis is about rolling out an existing product (regardless of what my opinion of the product is).
Considering the simplicity of the Petrozene product, if the purchased facility is running, Freestone should have access to sufficient Petrozene to start producing sales. Sales probably won't show up in the next Q report, but we should see costs associated with generating sales ramping up. The NEXT Q report should be the telling one. If that shows sales, FSNR may have a viable product with a market. If that doesn't show sales, Petrozene is very likely a dud with the industry.
News 
Market Data 
Discover 
